<http://purl.org/dc/elements/1.1/title>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<https://w3id.org/biolink/vocab/in_taxon>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.obolibrary.org/obo/GO_0008150>
        a       <http://www.w3.org/2002/07/owl#Class> .

<http://model.geneontology.org/R-HSA-9652282>
        a       <http://www.w3.org/2002/07/owl#Ontology> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Imported from Reactome: https://reactome.org/content/detail/R-HSA-9652282" , "http://www.reactome.org" , "For logical inference, import the integrated tbox ontology http://purl.obolibrary.org/obo/go/extensions/go-lego-reacto.owl" ;
        <http://geneontology.org/lego/modelstate>
                "development" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "GOC:reactome_curators" ;
        <http://purl.org/dc/elements/1.1/date>
                "2024-05-16" ;
        <http://purl.org/dc/elements/1.1/title>
                "Drug-mediated inhibition of ERBB2 signaling - imported from: Reactome" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" ;
        <https://w3id.org/biolink/vocab/in_taxon>
                <http://purl.obolibrary.org/obo/NCBITaxon_9606> .

<http://www.w3.org/2004/02/skos/core#narrower>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.org/dc/elements/1.1/date>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://purl.org/dc/elements/1.1/contributor>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://www.geneontology.org/formats/oboInOwl#hasDbXref>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://www.w3.org/2004/02/skos/core#note>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://model.geneontology.org/R-HSA-9652282/R-HSA-9652282>
        a       <http://purl.obolibrary.org/obo/GO_0008150> , <http://www.w3.org/2002/07/owl#NamedIndividual> ;
        <http://www.w3.org/2000/01/rdf-schema#comment>
                "Signaling by ERBB2 can be pharmacologically inhibited with tyrosine kinase inhibitors (TKIs) (Nelson and Fry 2001, Xia et al. 2002, Wood et al. 2004, Rabindran et al. 2004, Gandreau et al. 2007, Jani et al. 2007, Li et al. 2008, Hichkinson et al. 2010, Traxler et al. 2014, Hanker et al. 2017), and therapeutic antibodies, such as trastuzumab (Hudziak et al. 1989, Carter et al. 1992, Pickl and Ries 2009, Maadi et al. 2018) and pertuzumab (Franklin et al. 2004)." ;
        <http://www.w3.org/2000/01/rdf-schema#label>
                "Drug-mediated inhibition of ERBB2 signaling" ;
        <http://purl.org/dc/elements/1.1/contributor>
                "Edited: Orlic-Milacic, Marija, 2019-11-01" , "GOC:reactome_curators" , "Reviewed: Kancha, Rama Krishna, 2019-11-03" , "Authored: Orlic-Milacic, Marija, 2019-06-28" ;
        <http://purl.org/dc/elements/1.1/date>
                "2024-05-16" ;
        <http://purl.org/pav/providedBy>
                "https://reactome.org" ;
        <http://www.geneontology.org/formats/oboInOwl#hasDbXref>
                "R-HSA-9652282" ;
        <http://www.w3.org/2004/02/skos/core#narrower>
                <http://model.geneontology.org/R-HSA-1227986/R-HSA-1227986> ;
        <http://www.w3.org/2004/02/skos/core#note>
                "org.biopax.paxtools.model.level3.Pathway" .

<http://purl.org/pav/providedBy>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .

<http://geneontology.org/lego/modelstate>
        a       <http://www.w3.org/2002/07/owl#AnnotationProperty> .
